Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.57 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | NLRP3 | Q96P20 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23657593 | 0.88 | LMNA (0.72) | LMNAPPARAALDH1A1DNMT3AHDAC1 | |
| SCHEMBL11464602 | 0.87 | PTGER4 (0.69) | LMNAPPARAALDH1A1DNMT3APTGER4 | |
| SCHEMBL11516368 | 0.85 | LMNA (0.68) | LMNAPPARAALDH1A1DNMT3AHDAC1 | |
| SCHEMBL14507295 | 0.83 | DNMT3A (0.56) | LMNAPPARAALDH1A1DNMT3APTGER4 | |
| SCHEMBL14507292 | 0.83 | HPGD (0.71) | LMNAALDH1A1RAB9ASMN1; SMN2HDAC1 | |
| SCHEMBL12838811 | 0.82 | ALDH1A1 (0.76) | LMNAALDH1A1DNMT3AMEN1KMT2A | |
| SCHEMBL11356211 | 0.82 | LMNA (0.64) | LMNAPPARADNMT3APTGER4HDAC1 | |
| SCHEMBL17339437 | 0.81 | LMNA (0.62) | LMNAPPARAALDH1A1DNMT3AHDAC1 | |
| SCHEMBL29617795 | 0.81 | LMNA (0.62) | LMNAPPARAALDH1A1DNMT3AHDAC1 | |
| SCHEMBL11706059 | 0.81 | DNMT3A (0.72) | LMNAPPARADNMT3AHDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070124839-A1 | Active substances for increasing the stress defense in plants to abiotic stress, and methods of finding them | BAYER CROPSCIENCE GMBH (DE) | 2007-05-31 | — | — | US | disclosed |
| US-20070015661-A1 | Herbicide/safener combination | BAYER CROPSCIENCE GMBH (DE) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015661-A1 | Herbicide/safener combination | CBR3, CBR1, GSR | LMNA 3838/4885PPARA 1514/4885ALDH1A1 630/4885 |
| US-20070124839-A1 | Active substances for increasing the stress defense in plants to abiotic stress, and methods of finding them | HSF1, HSPA2, HSPA8 | LMNA 4564/4885PPARA 2238/4885ALDH1A1 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.